Saúde Pública/Medicina Humanitária

Nova diretriz AAP recomenda o rastreamento de rotina para HIV para todos os jovens de 15 anos ou mais.

10 Jan, 2022 | 12:20h

Adolescents and Young Adults: The Pediatrician’s Role in HIV Testing and Pre- and Postexposure HIV Prophylaxis – Pediatrics

Comentário: Pediatricians Can Play Key Role in HIV Testing, Prophylaxis – HealthDay

Estudo randomizado | Tratamento antirretroviral de baixo custo e de fácil adesão, baseado em dolutegravir, como terapia de primeira ou segunda linha foi não inferior ao tratamento padrão da infecção por HIV-1 em crianças.

10 Jan, 2022 | 12:13h

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentário: Easy-to-take medicine better at suppressing HIV in children – University College London

Comentários no Twitter

Dolutegravir-based antiretroviral therapy was compared with standard care in children and adolescents starting first- or second-line therapy for HIV type 1 infection. Dolutegravir-based ART was superior to standard-care ART. https://t.co/PP0XaEVswO pic.twitter.com/pQvhjdXcUk

— NEJM (@NEJM) December 29, 2021

Visual Abstract: Dolutegravir as First- or Second-Line HIV Treatment in Children https://t.co/2RIg9uH2V1 pic.twitter.com/mDr1Z6l6CJ

— NEJM (@NEJM) January 4, 2022

FDA aprova o primeiro tratamento injetável para profilaxia pré-exposição ao HIV.

10 Jan, 2022 | 12:09h

FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention – U.S. Food & Drug Administration

Comentários:

NIH celebrates FDA approval of long-acting injectable drug for HIV prevention – NIH News Releases

A new injection to prevent HIV, rather than pills, is a game-changer, scientists say – NPR

Conteúdos relacionados:

CDC Guidance: Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents

Study Shows High Burden of STI Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection

USPSTF Statement: Preexposure Prophylaxis for the Prevention of HIV Infection

British Guidelines on the Use of HIV Pre–exposure Prophylaxis (PrEP) (várias diretrizes sobre o tema)

New Protocol for HIV Prevention Drug Reduces The Number Of Pills Required

OMS emite recomendações provisórias para os esquemas de vacinação heteróloga contra COVID-19.

17 Dez, 2021 | 12:34h

Interim recommendations for heterologous COVID-19 vaccine schedules – World Health Organization

Comentário: Coronavirus: WHO gives the nod for mix-and-match vaccine schedules – South China Morning Post

Estudo randomizado com cerca de 30.000 indivíduos mostrou que a vacina Novavax foi segura e teve eficácia geral de 90,4% contra infecções sintomáticas por Covid-19.

17 Dez, 2021 | 12:31h

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico – New England Journal of Medicine

Comentários:

Novavax COVID vaccine shows 90.4% efficacy against infection – CIDRAP

Novavax COVID-19 vaccine found to be safe and effective – University of Maryland School of Medicine

Conteúdo relacionado: [Preprint] In RCT with 29,949 participants, the Novavax vaccine demonstrated high overall efficacy (>90%) for the prevention of Covid-19, and all moderate-to-severe cases occurred in placebo recipients. (vários artigos sobre o tema)

Covid-19: dados iniciais mostram que coriza, dor de cabeça e fadiga são os sintomas mais comuns da infecção pela variante Ômicron.

17 Dez, 2021 | 12:24h

Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show – The BMJ

Ver também: Omicron and cold-like symptoms rapidly taking over in London – ZOE COVID Study

Comentário no Twitter

The UK government has been urged to update its list of symptoms for covid-19, after early data showed cold-like symptoms of a runny nose, headache, fatigue, sneezing, and sore throat were the most commonly reported by people with the new omicron variant https://t.co/n6OJYIDTgf

— The BMJ (@bmj_latest) December 16, 2021

Conselheiros do CDC recomendam o uso preferencial de vacinas mRNA contra COVID em vez da vacina da J&J.

17 Dez, 2021 | 12:20h

CDC advisors recommend mRNA COVID vaccines over J&J – CIDRAP

Opinião | Estratégias de vacinação contra COVID-19 devem focar na doença grave e na equidade global.

17 Dez, 2021 | 12:19h

COVID-19 vaccine strategies must focus on severe disease and global equity – The Lancet

Como as vacinas contra COVID moldaram 2021, em 8 gráficos.

17 Dez, 2021 | 12:17h

How COVID vaccines shaped 2021 in eight powerful charts – Nature

Modelagem da mortalidade por COVID-19 em 44 países: uso de máscaras pode reduzir as mortes.

16 Dez, 2021 | 13:08h

Modeling COVID-19 Mortality Across 44 Countries: Face Covering May Reduce Deaths – American Journal of Preventive Medicine

Comentário: Mask laws could prevent unnecessary COVID-19 deaths, study shows – News Medical